TRIPLE HELIX BIOTECHNOLOGY LTD

Executive Summary

Triple Helix Biotechnology Ltd is a start-up biotech company with a stable but modest asset base and low liabilities. The company is currently loss-making with a significant drop in cash reserves over the past year, highlighting liquidity risk. Credit approval is conditional on continued monitoring of cash flow, profitability improvements, and management’s ability to secure additional funding to support ongoing operations.

View Full Analysis Report →
Company Documents

DateDescription
18/11/2418 November 2024 Confirmation statement made on 2024-11-16 with no updates

View Document

12/11/2412 November 2024 Change of details for Mr Zijie Wang as a person with significant control on 2024-09-15

View Document

12/11/2412 November 2024 Director's details changed for Mr Zijie Wang on 2024-09-15

View Document

06/11/246 November 2024 Change of details for Mr Da Lin as a person with significant control on 2021-11-24

View Document

25/10/2425 October 2024 Total exemption full accounts made up to 2023-11-30

View Document

30/11/2330 November 2023 Annual accounts for year ending 30 Nov 2023

View Accounts

16/11/2316 November 2023 Confirmation statement made on 2023-11-16 with no updates

View Document

17/08/2317 August 2023 Total exemption full accounts made up to 2022-11-30

View Document

30/11/2230 November 2022 Annual accounts for year ending 30 Nov 2022

View Accounts

24/11/2224 November 2022 Notification of Zijie Wang as a person with significant control on 2021-11-24

View Document

24/11/2224 November 2022 Confirmation statement made on 2022-11-16 with updates

View Document

22/11/2222 November 2022 Change of details for Mr Da Lin as a person with significant control on 2022-07-01

View Document

22/11/2222 November 2022 Director's details changed for Mr Da Lin on 2022-07-01

View Document

09/02/229 February 2022 Appointment of Bird & Bird Company Secretaries Limited as a secretary on 2022-02-08

View Document

24/01/2224 January 2022 Statement of capital following an allotment of shares on 2021-11-24

View Document

17/11/2117 November 2021 Incorporation

View Document


More Company Information